These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 31180642)
21. Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine. Kao JY; Gong Y; Chen CM; Zheng QD; Chen JJ J Immunol; 2003 Apr; 170(7):3806-11. PubMed ID: 12646647 [TBL] [Abstract][Full Text] [Related]
22. Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Liu Q; Zhai B; Yang W; Yu LX; Dong W; He YQ; Chen L; Tang L; Lin Y; Huang DD; Wu HP; Wu MC; Yan HX; Wang HY Mol Ther; 2009 Dec; 17(12):2049-57. PubMed ID: 19773743 [TBL] [Abstract][Full Text] [Related]
23. A photo-responsive self-healing hydrogel loaded with immunoadjuvants and MoS Wang S; Qian Z; Xiao H; Yang G; Zhu Z; Gu Y; Song J; Zhang X; Huang X; Weng L; Gao Y; Yang W; Wang L Nanoscale; 2024 May; 16(17):8417-8426. PubMed ID: 38591110 [TBL] [Abstract][Full Text] [Related]
24. Melanin-loaded CpG DNA hydrogel for modulation of tumor immune microenvironment. Wu Y; Li Q; Shim G; Oh YK J Control Release; 2021 Feb; 330():540-553. PubMed ID: 33373649 [TBL] [Abstract][Full Text] [Related]
25. Achieving traceless ablation of solid tumors without recurrence by mild photothermal-chemotherapy of triple stimuli-responsive polymer-drug conjugate nanoparticles. Du C; Ding Y; Qian J; Zhang R; Dong CM J Mater Chem B; 2019 Jan; 7(3):415-432. PubMed ID: 32254729 [TBL] [Abstract][Full Text] [Related]
26. Neutrophil infiltration and whole-cell vaccine elicited by N-dihydrogalactochitosan combined with NIR phototherapy to enhance antitumor immune response and T cell immune memory. Qi S; Lu L; Zhou F; Chen Y; Xu M; Chen L; Yu X; Chen WR; Zhang Z Theranostics; 2020; 10(4):1814-1832. PubMed ID: 32042338 [TBL] [Abstract][Full Text] [Related]
27. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599 [TBL] [Abstract][Full Text] [Related]
28. An amphiphilic dendrimer as a light-activable immunological adjuvant for in situ cancer vaccination. Wang Y; Gong N; Ma C; Zhang Y; Tan H; Qing G; Zhang J; Wang Y; Wang J; Chen S; Li X; Ni Q; Yuan Y; Gan Y; Chen J; Li F; Zhang J; Ou C; Zhao Y; Liu X; Liang XJ Nat Commun; 2021 Aug; 12(1):4964. PubMed ID: 34400628 [TBL] [Abstract][Full Text] [Related]
29. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs. Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753 [TBL] [Abstract][Full Text] [Related]
30. Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine. Jahan ST; Sadat SM; Haddadi A Int J Nanomedicine; 2018; 13():367-386. PubMed ID: 29391795 [TBL] [Abstract][Full Text] [Related]
31. Modulation of tumor microenvironment using a TLR-7/8 agonist-loaded nanoparticle system that exerts low-temperature hyperthermia and immunotherapy for in situ cancer vaccination. Chen PM; Pan WY; Wu CY; Yeh CY; Korupalli C; Luo PK; Chou CJ; Chia WT; Sung HW Biomaterials; 2020 Feb; 230():119629. PubMed ID: 31767446 [TBL] [Abstract][Full Text] [Related]
32. Genome-Editing-Mediated Restructuring of Tumor Immune Microenvironment for Prevention of Metastasis. Kim D; Wu Y; Shim G; Oh YK ACS Nano; 2021 Nov; 15(11):17635-17656. PubMed ID: 34723493 [TBL] [Abstract][Full Text] [Related]
33. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075 [TBL] [Abstract][Full Text] [Related]
34. Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors. Luo L; Yang J; Zhu C; Jiang M; Guo X; Li W; Yin X; Yin H; Qin B; Yuan X; Li Q; Du Y; You J J Control Release; 2018 May; 278():87-99. PubMed ID: 29626502 [TBL] [Abstract][Full Text] [Related]
35. Improved Antitumor Efficacy of Combined Vaccine Based on the Induced HUVECs and DC-CT26 Against Colorectal Carcinoma. Zhang Q; Xie C; Wang D; Yang Y; Liu H; Liu K; Zhao J; Chen X; Zhang X; Yang W; Li X; Tian F; Dong Z; Lu J Cells; 2019 May; 8(5):. PubMed ID: 31121964 [TBL] [Abstract][Full Text] [Related]
36. Tetradecanol-wrapped, CpG-loaded porous Prussian blue nanoimmunomodulator for photothermal-responsive in situ anti-tumor vaccine-like immunotherapy. Yin C; Xing Y; Zhao P; Yin Y; Yao H; Xue J; Gu W Biomater Adv; 2024 Nov; 164():213996. PubMed ID: 39146604 [TBL] [Abstract][Full Text] [Related]
37. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine. Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821 [TBL] [Abstract][Full Text] [Related]
38. Extending antigen release from particulate vaccines results in enhanced antitumor immune response. Kapadia CH; Tian S; Perry JL; Sailer D; Christopher Luft J; DeSimone JM J Control Release; 2018 Jan; 269():393-404. PubMed ID: 29146244 [TBL] [Abstract][Full Text] [Related]
39. Hydrogel/nanoadjuvant-mediated combined cell vaccines for cancer immunotherapy. Yang A; Bai Y; Dong X; Ma T; Zhu D; Mei L; Lv F Acta Biomater; 2021 Oct; 133():257-267. PubMed ID: 34407475 [TBL] [Abstract][Full Text] [Related]
40. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]